BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 172 filers reported holding BLUEBIRD BIO INC in Q4 2014. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $36,807,000 | -12.7% | 252,100 | -6.1% | 1.13% | -20.9% |
Q2 2018 | $42,141,000 | -7.6% | 268,500 | +0.5% | 1.43% | -18.7% |
Q1 2018 | $45,607,000 | -1.4% | 267,100 | +2.8% | 1.76% | -12.5% |
Q4 2017 | $46,270,000 | +393.5% | 259,800 | +154.1% | 2.01% | +97.1% |
Q4 2014 | $9,376,000 | – | 102,227 | – | 1.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Rock Ventures, LLC | 3,313,974 | $78,939,000 | 22.36% |
HARBOURVEST PARTNERS LLC | 59,264 | $1,243,000 | 3.98% |
RA Capital Management | 467,418 | $9,806,000 | 1.14% |
HAMILTON LANE ADVISORS LLC | 88,628 | $1,859,000 | 1.08% |
COWEN INC. | 158,709 | $3,330,000 | 0.56% |
SPHERA FUNDS MANAGEMENT LTD. | 92,435 | $1,939,000 | 0.54% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 423,224 | $8,879,000 | 0.46% |
Camber Capital Management LP | 206,900 | $4,341,000 | 0.38% |
Eventide Asset Management | 25,700 | $539,000 | 0.17% |
SABBY MANAGEMENT, LLC | 102,035 | $2,141,000 | 0.14% |